Shares in 4D Medical have soared up to 33%, after the US FDA approved the company’s CT:VQ lung imaging test for ventilation perfusion. The news sent 4D shares soaring up to 40%. 4D Medical describes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback